COMP <GO>
CW vs ASML // REVENUE GROWTH (YOY)
Curtiss-Wright Corporation (NYSE) VS. ASML Holding N.V. New York Registry Shares (NASDAQ) • 15-METRIC TALLY: CW 5
— ASML 8
▲ REVENUE GROWTH (YOY) LEADER: CW
LAST: $496.74 (+4.03%) • MKT CAP: $18.35B
revenue-growth
12.10%
LAST: $1,675.70 (+0.77%) • MKT CAP: $645.84B
revenue-growth
-4.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CW VS. ASML)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CW | ASML | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 37.20% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 17.10% | 14.90% | +2.20 | CW | /roic <GO> |
| EV/EBITDA & P/E Valuation | 26.4x | 14.9x | +11.50 | ASML | /valuation <GO> |
| Free Cash Flow Yield | 3.02% | 3.99% | -0.97 | ASML | /fcf-yield <GO> |
| Operating Margin | 18.10% | 21.10% | -3.00 | ASML | /operating-margins <GO> |
| Net Profit Margin | 13.80% | 16.40% | -2.60 | ASML | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 12.10% | -4.40% | +16.50 | CW | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.19% | 0.00% | +0.19 | CW | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.46 | 3.87 | +2.59 | CW | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | CW | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.9 | 50.0 | -5.10 | ASML | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.30 | 1.31 | -0.01 | ASML | /macro-sensitivity <GO> |
| Forward P/E Multiple | 31.8x | 20.2x | +11.60 | ASML | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $18.35B | $645.84B | -$627.50B | ASML | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CW REV | ASML REV | CW GROSS % | ASML GROSS % | CW FCF | ASML FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.50B | — | 37.2% | — | $553.7M | — |
| FY 2024 | $3.12B | — | 37.0% | — | $483.3M | — |
| FY 2023 | $2.85B | — | — | — | $320.0M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CW // BETA 1.30
ASML // BETA 1.31